Feedback / Questions
hydrogen sulphide-releasing derivative of naproxen (ATB-346) - Antibe
https://www.businesswire.com/news/home/20200228005048/en/Antibe-Therapeutics-Announces-Enrollment-Patient-Phase-2B
Feb 28, 2020
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next